Experimental 'Drug Vesicles' injected into spine aim to fight lung cancer brain spread
NCT ID NCT07559097
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tests whether injecting methotrexate-loaded vesicles (tiny drug-carrying particles made from patients' own tumor cells) into the spinal fluid can safely treat lung cancer that has spread to the brain lining. About 14 adults who have failed standard treatments will receive the injections on a schedule. The study first finds the safest dose, then checks if it shrinks tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methotrexate-loaded vesicles (drug-carrying particles made from patients' own tumor cells)
- What this could lead to
- If it works, this could offer a new local treatment option for lung cancer that has spread to the brain lining, potentially controlling the disease and extending survival.
- What could go wrong
- This is a very early, small trial (14 people) testing safety and dosing first. The approach may not work or could cause serious side effects like nerve damage or infection from the spinal injections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS FROM LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wang Qiming
RECRUITINGZhengzhou, Henan, 450000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.